Next generation of weight management medications: implications for diabetes and CVD risk
about
Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles.Cardiovascular disease prevention strategies for type 2 diabetes mellitus.Pharmacological Prevention of Cardiovascular Outcomes in Diabetes Mellitus: Established and Emerging Agents.Proactive and Progressive Approaches in Managing Obesity.
P2860
Next generation of weight management medications: implications for diabetes and CVD risk
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Next generation of weight management medications: implications for diabetes and CVD risk
@ast
Next generation of weight management medications: implications for diabetes and CVD risk
@en
Next generation of weight management medications: implications for diabetes and CVD risk
@nl
type
label
Next generation of weight management medications: implications for diabetes and CVD risk
@ast
Next generation of weight management medications: implications for diabetes and CVD risk
@en
Next generation of weight management medications: implications for diabetes and CVD risk
@nl
prefLabel
Next generation of weight management medications: implications for diabetes and CVD risk
@ast
Next generation of weight management medications: implications for diabetes and CVD risk
@en
Next generation of weight management medications: implications for diabetes and CVD risk
@nl
P2860
P1476
Next generation of weight management medications: implications for diabetes and CVD risk
@en
P2093
K. J. Serodio
S. Wharton
P2860
P2888
P356
10.1007/S11886-015-0590-Z
P407
P577
2015-05-01T00:00:00Z
P5875
P6179
1038964525